In November, Moderna already confirmed its bad omens, recording losses of $3.6 billion in the third quarter of 2023, compared to the million dollars in revenue...
Bayer shares have managed to partially reduce the losses recorded at the opening. Two weeks ago, the German company announced that it was studying the spin-off...
The pharmaceutical company Eli Lilly has added that it will invest $100 million with the aim of boosting its footprint in the German biotechnology ecosystem. The...
Almirall reduced its net profit by 58.3% until the third quarter of 2023, with a figure of €14.4 million, compared to the 34.5 million euros registered...
Eli Lilly unites healthcare and research to create medicines that improve the lives of people around the world. Harnessing the power of biotechnology, chemistry, and genetics, its scientists are...
In 2022, the laboratory closed the financial year with a turnover of more than €272 million, an increase of 15.7% compared to 2021. In Spain, the...
More than half of the population of the countries of the Organization for Economic Cooperation and Development (OECD) was overweight or obese, according to the latest...
The gross margin of 64.9% has also been in line with expectations, reflecting the impact of the high cost of production goods and inflation that has...
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
The Barometer of Health Companies in Spain is an annual report that aims to be a useful tool for professionals in the sector when making strategic...